- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Avidity Biosciences Inc (RNA)
Assess today's live Avidity Biosciences Inc (RNA) share price, performance and insights using our live NASDAQ: RNA stock exchange data.
Analyse the historical data and Avidity Biosciences Inc share price performance charts on this page. Our technical summary section provides analysis on Avidity Bio share price buy/sell indicators using real-time data (or discuss the Avidity Bio (RNA) stock price today with other investors in the Avidity Bio NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ RNA share price (ISIN: US05370A1088) to enhance your trading decisions with our free investment tools and resources.
What Is the Avidity Biosciences Inc Share Price Today?
The Avidity Bio share price today is 72.14.
What Is the Stock Symbol for Avidity Biosciences Inc
The stock symbol (or 'ticker') for Avidity Biosciences Inc is "RNA."
What Stock Exchange Does Avidity Biosciences Inc Trade On?
Avidity Biosciences Inc is listed and trades on the NASDAQ stock exchange.
Is Avidity Biosciences Inc a Good Stock to Buy?
Determining whether Avidity Biosciences Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Analyse the historical data and Avidity Biosciences Inc share price performance charts on this page. Our technical summary section provides analysis on Avidity Bio share price buy/sell indicators using real-time data (or discuss the Avidity Bio (RNA) stock price today with other investors in the Avidity Bio NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ RNA share price (ISIN: US05370A1088) to enhance your trading decisions with our free investment tools and resources.
What Is the Avidity Biosciences Inc Share Price Today?
The Avidity Bio share price today is 72.14.
What Is the Stock Symbol for Avidity Biosciences Inc
The stock symbol (or 'ticker') for Avidity Biosciences Inc is "RNA."
What Stock Exchange Does Avidity Biosciences Inc Trade On?
Avidity Biosciences Inc is listed and trades on the NASDAQ stock exchange.
Is Avidity Biosciences Inc a Good Stock to Buy?
Determining whether Avidity Biosciences Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
NASDAQ
Currency in USD
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
72.05
72.19
52 wk Range
21.51
72.61
RNA is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
72.0572.19
52 wk Range
21.5172.61
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
RNA Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Neutral
Price Target
74.64
Upside
+3.46%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Analysts anticipate sales growth in the current year
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Buy
Moving Averages
Buy
Avidity Bio Company Profile
Avidity Biosciences, Inc., a biopharmaceutical company, engages in the delivery of RNA therapeutics called antibody oligonucleotide conjugates (AOCs). Its AOC platform is designed to combine the specificity of monoclonal antibodies with the precision of RNA therapeutics to target the root cause of diseases previously untreatable with such therapeutics. The company’s pipeline has three programs in registrational clinical trials, such as Delpacibart etedesiran, which is in Phase 3 development stage for the treatment of people with myotonic dystrophy type 1; Delpacibart braxlosiran that is in Phase 1/2 development stage for treating facioscapulohumeral muscular dystrophy; and Delpacibart zotadirsen, which is in the Phase 2 EXPLORE44 open-label extension study for the treatment of Duchenne muscular dystrophy. The company is also developing precision cardiology candidates targeting rare genetic cardiomyopathies, including AOC 1086 for phospholamban cardiomyopathy and AOC 1072 for protein kinase AMP-activated non-catalytic subunit gamma 2 syndrome. Avidity Biosciences, Inc. was incorporated in 2012 and is headquartered in San Diego, California.
Avidity Biosciences Inc SWOT Analysis
Pioneering Therapies | Avidity Biosciences leads in rare muscle disease treatments, with promising clinical trials for DM1, FSHD, and DMD, positioning for market leadership |
Financial Health | Strong cash position funds operations into 2027, with analysts projecting significant upside potential despite near-term negative EPS forecasts |
Market Opportunity | Explore the multi-billion dollar potential in rare muscle diseases, with FSHD market alone estimated at $4-5 billion and DMD sales projections of $400 million |
Analyst Optimism | Consensus price targets range from $57 to $96, reflecting confidence in Avidity's innovative muscle-targeting technology and pipeline progress |
Compare RNA to Peers and Sector
Metrics to compare | RNA | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipRNAPeersSector | |
|---|---|---|---|---|
P/E Ratio | −19.8x | −3.9x | −0.6x | |
PEG Ratio | 0.42 | 0.04 | 0.00 | |
Price/Book | 5.8x | 2.1x | 2.6x | |
Price / LTM Sales | 520.9x | 6.2x | 3.2x | |
Upside (Analyst Target) | −0.2% | 109.7% | 41.8% | |
Fair Value Upside | Unlock | 6.2% | 5.1% | Unlock |
Analyst Ratings
2 Buy
12 Hold
0 Sell
Ratings:
14 analysts
Overall Consensus
Neutral
Analysts 12-Month Price Target:
Average 74.64
(+3.46% Upside)
Earnings
Latest Release
Nov 10, 2025
EPS / Forecast
-1.27 / -1.14
Revenue / Forecast
12.48M / 1.93M
People Also Watch
FAQ
What Is the Avidity Bio (RNA) Share Price Today?
The live Avidity Bio share price today is 72.14
What Stock Exchange Does Avidity Bio (RNA) Trade On?
Avidity Bio is listed and trades on the Nasdaq Stock Exchange.
What Is the Ticker (Stock Symbol) for Avidity Bio?
The stock symbol (also called a 'ticker') for Avidity Bio is "RNA."
What Is the Current Avidity Bio Market Cap?
As of today, Avidity Bio market capitalisation is 10.87B.
What Is Avidity Bio's (RNA) Earnings Per Share (TTM)?
The Avidity Bio EPS is currently -4.19 (Trailing Twelve Months).
When Is the Next Avidity Bio Earnings Date?
Avidity Bio's next earnings report will be released on 03 Mar 2026.
Is RNA a Buy or Sell From a Technical Analyst Perspective?
Based on today's Avidity Bio moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Avidity Bio Stock Split?
Avidity Bio has split 0 times. (See the RNA stock split history page for full effective split date and price information.)
How Many Employees Does Avidity Bio Have?
Avidity Bio has 391 employees.
What is the current trading status of Avidity Bio (RNA)?
As of 24 Dec 2025, Avidity Bio (RNA) is trading at a price of 72.14, with a previous close of 72.14. The stock has fluctuated within a day range of 72.05 to 72.19, while its 52-week range spans from 21.51 to 72.61.
What Is Avidity Bio (RNA) Price Target According to Analysts?
The average 12-month price target for Avidity Bio is USD74.63636, with a high estimate of USD96 and a low estimate of USD72. 2 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Neutral. The stock has an +3.46% Upside potential.
What Is the RNA After Hours Price?
RNA's last after hours stock price is 72.17, the stock has decreased by 0.03, or 0.04%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.